Anti-tumor therapies which are suggested to significantly suppress tumor growth were totally considered to increase the CD44lowCD62Lhi memory T cells and CD44hiCD62Lhi TCM cells of the tumor-infiltrating CD4 and CD8 T cells in breast cancer (24). This evidence concerns the gene CD8A and breast cancer.